Philip M. Arlen, MD | Authors

Prostate Cancer Immunotherapy: the Role for Sipuleucel-T and Other Immunologic Approaches

March 17, 2011

For many years, the results of large randomized clinical trials of cancer vaccines have not been good.

Commentary (Schlom et al): Novel Vaccines for the Treatment of Gastrointestinal Cancers

November 01, 2005

Dr. Marshall has done an excellentjob in his review of thecurrent status of the design,development, and delivery of cancervaccines with emphasis on vaccinesfor the treatment of gastrointestinalcancers. He has clearly delineated boththe promise and potential limitationsof this actively emerging field ofinvestigation.